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Abstract-The balance between endothelial nitric oxide (NO) and angiotensin II (Ang II) maintains the homeostasis of the cardiovascular and renal systems. We tested the hypothesis that increased oxidant stress linked to a functional imbalance between NO and Ang II might play a central pathogenetic role in salt-sensitive (SS) hypertension. We studied Dahl SS (DS) rats during the prehypertensive (5 days) and hypertensive (12 weeks) phases of a high-salt (4% NaCl) diet. Control rats received a normal-salt (0.5% NaCl, [NS]) diet. Prehypertensive DS rats (systolic blood pressure [SBP] 138Ϯ2 mm Hg) manifested a 35% increase (PϽ0.05) in aortic superoxide (O 2 -) production without evidence of end-organ damage. Hypertensive DS rats (SBP 214Ϯ11 mm Hg) had impaired endothelium-dependent relaxation (EDR) and increased aortic O 2 -production (320%), urinary isoprostane excretion (83%), aortic (20%) and left ventricular (LVH, 21%) hypertrophy, and proteinuria (124%). In prehypertensive DS rats, candesartan (10 mg · kg Ϫ1 · d
Ϫ1
) an Ang II type 1 receptor blocker (ARB), normalized O 2 -production. In hypertensive DS rats, the ARB decreased aortic O 2 -production by 71% and normalized EDR without affecting SBP (212Ϯ8 mm Hg), aortic hypertrophy, LVH, or proteinuria. Switching hypertensive DS rats to an NS diet did not affect SBP (208Ϯ8 mm Hg), LVH, aortic hypertrophy, or proteinuria and had minimal effects on O 2 -and EDR. Concomitant ARB administration plus a switch to an NS diet normalized SBP (138Ϯ8 mm Hg) as well as end-organ damage. Dahl salt-resistant rats fed an HS diet for 12 weeks did not show hypertension or increased O 2 -production. Thus, SS hypertension might represent a specific vascular diathesis linked to functional upregulation of Ang II action (increased O 2 -synthesis) accompanied by insufficient NO bioavailability, which promotes severe endothelial dysfunction. Key Words: angiotensin II Ⅲ endothelium Ⅲ nitric oxide Ⅲ oxidative stress Ⅲ hypertension, sodium-dependent E xtensive studies of the relation between salt and blood pressure have established that some individuals are sensitive to dietary salt changes, whereas others are resistant. 1 Epidemiologically, salt sensitivity (SS) affects Ϸ50% of hypertensive patients and 20% of normotensive patients. 2 SS hypertensive patients almost uniformly have low plasma renin levels and often manifest microalbuminuria. 3 SS hypertension, which is more prevalent in blacks and the elderly, has traditionally been considered a "volume-dependent hypertension," in which the role of angiotensin II (Ang II) was presumed to be irrelevant because of suppressed plasma renin. 4 However, recent studies in Dahl SS (DS) rats, a well-known model of SS hypertension, have suggested that SS hypertension is accompanied by increased activation of the local renal renin-angiotensin system. [5] [6] [7] On the basis of these studies, we hypothesize that functional upregulation of the renin-angiotensin system linked to a concomitant decrease in the bioactivity of nitric oxide (NO) might be an important contributor to the pathophysiology of endothelial dysfunction and end-organ injury in SS hypertension. 8 -10 There is an antagonistic interaction between endothelial NO and Ang II, [11] [12] [13] and the balance between NO and Ang II appears crucial for maintaining homeostasis of the cardiovascular and renal systems, 13 particularly for regulation of vascular tone and modulation of growth-related pathologic changes. 14 The functional interaction is such that a reduction in NO bioactivity represents a proportional increment in the bioactivity of Ang II. 15 Furthermore, recent studies have reported that long-term inhibition of NO synthesis actually results in upregulation of the synthesis of Ang II, as well as expression of the Ang II type 1 (AT 1 ) receptor. 16 Ang II activates NADH/NADPH oxidase in endothelial cells, vascular smooth muscle cells, adventitial fibroblasts, and glomerular mesangial cells. [17] [18] [19] [20] NADH/NADPH oxidase in turn produces superoxide anion (O 2 -), which avidly interacts with NO, reduces its bioactivity, and generates peroxynitrite. [21] [22] [23] Elegant studies in patients with renovascular hypertension 24 as well as ex vivo studies of human arteries have demonstrated that the biologic interaction between Ang II, O 2 -, and NO is fully operative in humans. 25 The DS rat is a paradigm of low plasma renin, SS hypertension. 26 We have previously shown that hypertensive DS rats downregulate endothelial NO synthase (eNOS) and develop impaired NO-mediated endothelial function, accompanied by cardiovascular and renal injury. 10, 27 It has been shown that levels of Ang II and angiotensinogen are increased in the kidney and heart of hypertensive DS rats. [5] [6] [7] Moreover, recent studies have reported that vascular oxidative stress might be increased in hypertensive DS rats, 28, 29 although the mechanisms involved were not elucidated.
In the present study, we used DS rats to test the hypothesis that the vascular phenotype of SS, low-renin hypertension is one of endothelial dysfunction and functional upregulation of Ang II, accompanied by susceptibility to the development of cardiovascular and renal injury. The studies reported herein support the notion that SS might represent a vascular diathesis linked to functional upregulation of Ang II actions, accompanied by insufficient NO bioavailability. These studies also suggest that increased oxidant stress is associated with the functional imbalance between NO and Ang II.
Methods

Animals and Experimental Protocols
In pilot studies, we determined that DS rats fed a high-salt (HS) diet containing 4% NaCl do not manifest an increase in systolic blood pressure (SBP) during the first 5 days but become progressively hypertensive thereafter. We studied groups of 6-week-old DS rats (Harlan, Indianapolis, Ind) during the prehypertensive (5 days) and hypertensive (12 weeks) phases of the HS diet. The prehypertensive DS rats were divided into 3 groups: HS, DS rats fed an HS diet (nϭ11); HSϩARB, DS rats fed an HS diet plus the AT 1 receptor blocker (ARB) candesartan (10 mg · kg Ϫ1 · d Ϫ1 by gavage, nϭ7); and NS, DS rats fed a normal-sodium (NS) diet containing 0.5% NaCl (nϭ9). Rats in the hypertensive phase were divided into 5 groups: HS, DS rats fed an HS diet (nϭ6); HSϩARB, DS rats fed an HS diet plus candesartan (10 mg · kg Ϫ1 · d Ϫ1 by gavage, nϭ5); HS/NS, DS rats fed an HS diet for 6 weeks and then switched to an NS diet for 6 weeks (nϭ6); HS/NSϩARB, DS rats fed an HS diet for 6 weeks followed by 6 weeks of the NS diet plus candesartan (nϭ6); and NS, DS rats fed an NS diet throughout (nϭ6). SBP was measured by the tail-cuff method. 27 Urine protein concentration was determined by a commercially available method (Bio-Rad). 27 A separate group of Dahl salt-resistant (DR) rats were given a diet containing either 0.5% NaCl (NS, nϭ4) or 4% NaCl (HS, nϭ7) for 12 weeks. Aortic rings from DR rats were used for measuring O 2 -by lucigenin chemiluminescence, as described subsequently.
Detection of O 2 -Generation by Lucigenin Chemiluminescence
Measurement of O 2 -in intact aortic rings was performed by using the chemiluminescence of lucigenin, as previously described. 20 Some rings were incubated with 10 mol/L diphenylene iodonium (DPI), 10 mol/L indomethacin, 100 mol/L oxypurinol, 100 mol/L N w nitro-L-arginine (L-NAME), or 100 mol/L tetrahydrobiopterin (BH 4 ) to examine the potential role of NADH/NADPH oxidase, cyclooxygenase pathways, xanthine oxidase, NOS, and NOS cofactors, respectively, in the synthesis of O 2 -. All O 2 -measurements were adjusted for milligrams dry weight and expressed as counts per minute per milligram dry tissue per minute.
In Situ O 2 -Measurement by Confocal Fluorescence Microscopy
The oxidative fluorescent dye hydroethidine was used to evaluate in situ O 2 -generation. 30 In brief, fresh aortic rings embedded in OCT compound were cut into 10-m-thick sections, submerged in 2 mol/L dihydroethidium in HEPES buffer, and incubated at 37°C for 30 minutes. At the end of this incubation period, the slides were washed with phosphate-buffered saline and kept at 4°C. Images were obtained with a Bio-Rad MRC-1024 laser scanning confocal microscope. Fluorescence was detected with a 585-nm long-pass filter and stored digitally.
Urine Isoprostane Excretion
Urinary isoprostanes were measured by an enzymatic immunoassay and by following the manufacturer's instructions (Cayman). Results were expressed as nanograms per milligram creatinine.
Organ Chamber Experiments
Endothelial function was examined in aortic rings in an organ chamber bath, as previously described. 10 Endothelium-dependent relaxation (EDR) in response to acetylcholine (Ach, 10 Ϫ9 to 10 Ϫ5 mol/L) was studied in rings precontracted to 70% of maximal contraction to norepinephrine. 10 
Data Analysis
The data were expressed as meanϮSEM. Statistical analyses were performed by ANOVA (Stat-View). Results were considered significant when PϽ0.05.
Results
Blood Pressure
DS rats fed an HS diet for 5 days did not have an increase in SBP compared with the NS controls ( Table 1 ). In contrast, the HS diet given for 12 weeks significantly increased SBP in DS rats compared with NS controls (Table 2 and Figure 1 ). A few HS rats studied for 12 weeks were sacrificed by decapitation before schedule because of complications from high blood pressure, especially strokes. Neither treatment with the ARB candesartan (HSϩARB) nor a return to an NS diet (HS/NS) after 6 weeks of the HS diet resulted in a significant reduction in SBP. However, treatment with the ARB combined with removal of the HS diet (HS/NSϩARB) reduced SBP to levels even below those of control NS rats (Table 2 and Figure 1 )
Urinary Protein Excretion
An HS diet for 5 days did not result in significant proteinuria compared with the control NS group (Table 1) . In contrast, an HS diet for 12 weeks resulted in a significant increase in urinary protein excretion (Table 2 ). In hypertensive HS rats, neither the ARB (HSϩARB) nor removal of the HS diet (HS/NS) alone significantly reduced proteinuria. However, simultaneous treatment with the ARB and removal of the HS NS indicates DS rats fed a 0.5% NaCl diet for 5 days; HS, DS rats fed a 4% NaCl diet for 5 days; HSϩARB, DS rats fed a 4% NaCl diet plus candesartan (10 mg/kg per day, by gavage) for 5 days; HW, heart weight; AoW, aortic weight; and ND, not done. Data are expressed as meanϮSEM.
diet (HS/NSϩARB) reduced proteinuria to levels below those of control NS rats (Table 2 ).
Aortic and LV Hypertrophy
An HS diet for 5 days did not have a significant effect on aortic weight or left ventricle (LV) weight-to-body weight ratio (LVW/BW; Table 1 ). In contrast, an HS diet for 12 weeks significantly increased aortic weight and the LVW-BW ratio (Figure 2 ). In hypertensive HS rats, neither a return to an NS diet (HS/NS) nor treatment with the ARB (HSϩARB) alone reduced aortic weight or the LVW-BW ratio. However, simultaneous treatment with the ARB and reinstitution of an NS diet (HS/NSϩARB) normalized both aortic weight and the LVW-BW ratio.
Vascular O 2 -Production
An HS diet for 5 days significantly increased aortic O 2 -production by 35% compared with NS, as assessed by chemiluminescence of lucigenin ( Figure 3) . Treatment with the ARB (HSϩARB) prevented the increase in aortic O 2 -, which suggests that activation of the AT 1 receptor mediated the increased O 2 -production in these rats ( Figure 3 ). Furthermore, aortic rings from rats fed an HS diet for 5 days showed an increase in O 2 -production, as assessed by laser confocal fluorescence microscopy, compared with aortic rings from rats fed the NS diet. The increased fluorescence was evident in all vascular layers, including vascular smooth muscle, endothelial, and adventitial layers. In agreement with the studies with lucigenin, aortic rings from HS rats treated with the ARB (HSϩARB) showed a significant reduction in fluorescence (Figure 4) -production was less pronounced in the NS rats (28%) than in the prehypertensive HS rats (48%), suggesting that the increased NADH/NADPH oxidase activity is the source of increased O 2 -production in aortas from prehypertensive rats. In contrast, preincubation with indomethacin, BH 4 , or L-NAME did not reduce O 2 -production in any group of rats studied for 5 days, whether normotensive (NS) or prehypertensive (HS) (data not shown).
An HS diet for 12 weeks resulted in a 320% increase in aortic O 2 -production in hypertensive HS rats compared with NS rats (PϽ0.05). Return to an NS diet (HS/NS) resulted in a small but statistically insignificant reduction in O 2 -production ( Figure 5A ). Treatment with the ARB (HSϩARB) resulted in a 71% reduction in aortic O 2 -production ( Figure  5A ), even though it did not decrease SBP (Figure 1 ). In aortic rings from hypertensive HS rats studied ex vivo, preincubation with DPI, indomethacin, or L-NAME decreased O 2 -production by 45%, 28%, and 35%, respectively ( Figure 5B ). However, preincubation with the xanthine oxidase inhibitor oxypurinol had no effect on O 2 -production ( Figure 5B ), which suggests that in hypertensive HS rats, in addition to NADH/NADPH oxidase, cyclooxygenase 31 and uncoupling of NOS 32, 33 participate in the increased generation of aortic O 2 -. In contrast with DS rats, in DR rats an HS diet for 12 , by gavage); HS/NS, DS rats fed an HS diet for 6 weeks followed by an NS diet for 6 weeks; HS/NSϩARB, DS rats fed an HS diet for 6 weeks followed by an NS diet plus candesartan for 6 weeks. *PϽ0.05 vs HS, HSϩARB, and HS/NS. Data are expressed as meanϮSEM, nϭ5 or 6. NS indicates DS rats fed a 0.5% NaCl diet for 12 weeks; HS, DS rats fed a 4% NaCl diet for 12 weeks; HSϩARB, DS rats fed a 4% NaCl diet plus candesartan treatment (10 mg/kg per day, by gavage) for 12 weeks; HS/NS, DS rats fed a 4% NaCl diet for 6 weeks followed by 0.5% NaCl diet for 6 weeks; HS/NSϩARB, DS rats fed a 4% NaCl diet for 6 weeks followed by a 0.5% NaCl diet plus candesartan for 6 weeks; EDR, endothelium-dependent relaxation; E max , maximal response to Ach; ED 50 , the concentration of Ach causing a half-maximal response.
* Figure 5B ). Moreover, the production of O 2 -in aortas from ARBtreated rats (HSϩARB, 1451Ϯ88 counts · mg dry weight Ϫ1 · min Ϫ1 ; Figure 5A ) was similar to that in aortas from hypertensive HS rats incubated ex vivo with DPI (1371Ϯ78 counts · mg dry weight Ϫ1 · min Ϫ1 ; Figure 5B ). These findings strongly suggest that the reduction in aortic O 2 -production in rats treated with the ARB is due to reduced activation of NADH/NADPH oxidase.
Urinary Isoprostane Excretion
We measured the urinary excretion of isoprostanes as an additional marker of oxidative stress in vivo. Hypertensive HS rats manifested a significant increase in urinary isoprostane excretion (HS rats, 1.45Ϯ0.34 ng/mg creatinine vs NS rats, 0.79Ϯ0.11 ng/mg creatinine, PϽ0.05). These findings provide further evidence of increased O 2 -production in HS rats.
EDR to Ach
An HS diet for 5 days did not affect EDR to Ach ( Figure 6A ). In contrast, hypertensive HS rats showed a significant impairment of EDR to Ach when compared with NS rats. Return to an NS diet (HS/NS) increased the maximal relaxation to Ach but did not improve ED 50 to Ach (Table 2) . Strikingly, treatment with the ARB (HSϩARB) normalized EDR, even though this agent did not reduce the blood pressure of hypertensive HS rats ( Figure 6B ).
Discussion
The nitric oxide-renin-angiotensin axis plays a major role in the maintenance of cardiovascular and renal homeostasis. [35] [36] [37] The countervailing interaction between NO and Ang II extends beyond the fact that NO is a vasodilator and Ang II is a vasoconstrictor. 13 Indeed, NO downregulates the synthesis of Ang II as well as AT 1 receptors. 38 On the other hand, Ang II, at both pressor and subpressor doses, results in impaired NO-mediated EDR owing to an increase in vascular production of O 2 -, 24,39 which reduces NO bioavailability and generates peroxynitrite. [21] [22] [23] O 2 -originates from NADH/ NADPH oxidase, an enzyme that is known to be upregulated by Ang II via activation of the AT 1 receptor. 40 Peroxynitrite has been shown to induce the release of Zn 2ϩ from the zinc thiolate center of NOS, which results in NOS uncoupling 32 ; dysfunctional NOS produces more O 2 -than does NO. 33, 41 Dahl rats constitute a paradigm of SS hypertension in humans. 26 In previous studies, we demonstrated that hypertensive DS rats downregulate endothelial NOS activity and develop impaired NO-mediated endothelial function, accompanied by cardiovascular and renal injury. 10, 27 The glomerular injury of hypertensive DS rats is associated with increased expression of transforming growth factor-␤, a molecule that is upregulated by Ang II. 42 Moreover, the concentration of angiotensinogen and Ang II is increased in the kidneys of hypertensive DS rats on an HS diet, suggesting increased activation of the local renal renin-angiotensin system. 5, 6 In addition, studies have reported increased vascular O 2 -production in hypertensive DS rats, 28, 29, 43 although the mechanisms involved were not elucidated. In the present study, we investigated whether the increased O 2 -generation is linked to functional upregulation of Ang II in DS rats fed an HS diet. Initially, we demonstrated that prehypertensive DS rats fed an HS diet for 5 days did not develop either proteinuria or LV hypertrophy. However, during this prehypertensive stage, aortic O 2 -production was significantly increased. Confocal microscopy revealed that the increased O 2 -originated from all vascular layers. Because aortic O 2 -production was normalized by administration of the ARB in vivo and by DPI, an inhibitor of NADPH/NADH oxidase, ex vivo, we propose that in DS rats high dietary salt induces a functional upregulation of Ang II, which results in an NADH/NADPHdependent increase in O 2 -production. Obviously, during the prehypertensive stage, the increased O 2 -production is not of sufficient magnitude to decrease NO bioactivity and result in impaired EDR. Moreover, it is apparent that the amount of O 2 -produced is also not enough to generate peroxynitrite in amounts sufficient to induce a functional uncoupling of NOS, leading to increased O 2 -production by NOS itself. 32 The failure of both BH 4 and L-NAME to reduce aortic O 2 -production in HS rats supports the latter contention.
During the hypertensive phase, HS rats developed LV hypertrophy, aortic hypertrophy, proteinuria, and impaired EDR. Concomitantly, aortic O 2 -production was increased by 320%. In vivo administration of the ARB dramatically reduced O 2 -production and normalized NO-dependent EDR in response to Ach, although it did not control hypertension. It is known that a high-salt diet antagonizes the antihypertensive effects of angiotensin-converting enzyme inhibitors and ARBs. 44, 45 Switching HS rats from the HS diet to an NS diet (HS/NS rats) was not accompanied by a significant reduction in blood pressure, proteinuria, aortic and LV hypertrophy, or O 2 -production. Collectively, these findings strongly suggest that during the hypertensive phase, the increased O 2 -production as well as the endothelial dysfunction are maintained by a functional upregulation of Ang II. This contention is further supported by the studies ex vivo, which showed that DPI, an inhibitor of NADPH/NADH oxidase, reduced aortic O 2 -production by 45% and that indomethacin and L-NAME reduced O 2 -production by 28% and 35%, respectively. Remarkably, high dietary salt did not increase O 2 -production in DR rats. We have previously shown that DR rats fed high dietary salt do not develop hypertension or endothelial dysfunction. 27 In concert, these data suggest that in DS rats, high dietary salt promotes an increase in O 2 -production that is linked to functional upregulation of Ang II, which over time reduces NO bioactivity, leading to endothelial dysfunction. During the hypertensive phase, 2 other contributors to O 2 -production are recruited, namely, cyclooxygenase and NOS. In this context, it is known that O 2 -upregulates cyclooxygenase-2 46 and that O 2 -, interacting with NO, generates peroxynitrite, 22,23 which results in NOS uncoupling; dysfunctional NOS paradoxically produces more O 2 -than does NO. 32, 33, 41 In summary, our studies suggest that during the hypertensive phase, a vicious circle is established that maintains an increase in O 2 -production and impaired endothelial function.
The fact that in the hypertensive phase the ARB normalized O 2 -production and EDR, but not hypertension or end-organ damage, clearly suggests that endothelial NO- dependent vascular relaxation is exquisitely sensitive to O 2 -. These findings have important mechanistic implications because they (1) demonstrate that increased O 2 -production is linked to Ang II and not the hemodynamic stress of blood pressure; (2) provide evidence of the beneficial effects of Ang II blockade on the endothelium, independently of blood pressure control; and (3) establish that endothelial dysfunction by itself is not sufficient to maintain hypertension in SS hypertension. In this context, we have previously shown that vitamin E-deficient DS rats fed a high-cholesterol diet have increased oxidant stress accompanied by severe endothelial dysfunction but do not develop hypertension on an NS diet. 47 Similarly, CuZn superoxide dismutase-deficient mice manifest increased oxidant stress and impaired endothelial dysfunction but do not develop hypertension. 48 Clinically, endothelial dysfunction is a major marker of cardiovascular morbidity. 49 Our studies suggest, however, that to prevent or arrest end-organ injury, in addition to normalization of endothelial function, control of blood pressure is indispensable.
Perspectives
We used DS rats to test the hypothesis that there is an important interaction between Ang II, NO, and oxidative stress in SS hypertension. In SS hypertension, these studies unmasked a previously unrecognized participation of Ang II in the genesis of endothelial dysfunction that is linked to an increase in oxidative stress. Furthermore, in DS rats fed high dietary salt, the functional upregulation of Ang II occurred very early, even before DS rats become overtly hypertensive. In hypertensive rats, blockade of the AT 1 receptor normalized endothelial function despite the fact that it did not affect blood pressure. Consequently, our demonstration of a dissociation between endothelial function and blood pressure elevation in SS hypertension underscores that blockade of the AT 1 receptor confers an important, beneficial vascular effect. Our studies might have important clinical and therapeutic implications regarding the role of blood pressure and endothelial dysfunction in hypertensive end-organ disease. . EDR to Ach in aortic rings of prehypertensive (A) and hypertensive (B) DS rats. In prehypertensive DS rats, an HS diet for 5 days did not affect EDR to Ach (nϭ6). In contrast, an HS diet for 12 weeks significantly attenuated EDR to Ach. Treatment with ARB (HSϩARB) or treatment with ARB and salt removal normalized EDR to ACH. Groups are as described in text and the legend to Figure 1 . *PϽ0.05 vs NS, HSϩARB, and HS/NSϩARB, nϭ5 or 6.
